Clinical Trial Update: Additional KIF6 Risk Offers Better Adherence to Statins

View source ↗

Summary

The clinical trial update indicates that providing additional KIF6 genetic risk information may improve adherence to statin therapy in patients with cardiovascu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Dyslipidemia

Drugs mentioned

• Statins

Snippet

Sponsor: Medco Health Solutions, Inc. | Conditions: Cardiovascular Diseases, Dyslipidemia | Status: COMPLETED